Peply
← All Compounds

Inclusion of a compound does not constitute endorsement. Information sourced from published research and regulatory filings.

Kisspeptin-10

Cat 2 → Pending Cat 1

Longevity & Immune · Research peptide (multiple suppliers)

Decapeptide fragment of kisspeptin researched for reproductive hormone axis regulation. Not FDA-approved for any indication.


About

Mechanism
Decapeptide fragment of kisspeptin that activates KISS1R (GPR54) in hypothalamic GnRH neurons. Potently stimulates LH and FSH secretion, serving as a key regulator of the reproductive hormone axis.
Half-Life
Approximately 4 minutes (IV), 27 minutes (SC)
Route
subcutaneous
Frequency
Single dose (weight-based: 1-10 mcg/kg)

Clinical Dosing

75-750 mcgsingle dose (weight-based: 1-10 mcg/kg)

Not FDA-approved. Investigational use in reproductive endocrinology. Currently FDA Category 2 (restricted). Pending return to Category 1.

Dosing extrapolated from animal studies and community protocols. No large-scale human clinical trials.


Regulatory Status

FDA Category
Research peptide (FDA Category 2)
Reclassification
pending
Date Restricted
2023-09-29
Announced Return
2026-02-27

Status based on publicly available FDA communications. Verify at FDA.gov for authoritative guidance.

View full regulatory timeline →

Titration Protocols

Research Protocol

Source: Dhillo et al., Journal of Clinical Endocrinology & Metabolism, 2005

DoseDurationDraw (1 mg vial in 2mL)Notes
1 mcgMaintenance0.00 mL (< 1 units)Single SC dose (research); dose varies by protocol

Available Vial Sizes

1 mg

1 mg vial

5 mg

5 mg vial


Citations

  1. [1]Kisspeptin-54 Stimulates the Hypothalamic-Pituitary-Gonadal Axis in Human Males. Journal of Clinical Endocrinology & Metabolism, 90(12), 6609-6615. Link(Reviewed: 2026-02-27)